ATE395601T1 - Verfahren zum vorhersagen von preeclampsia und anderen krankheiten - Google Patents

Verfahren zum vorhersagen von preeclampsia und anderen krankheiten

Info

Publication number
ATE395601T1
ATE395601T1 AT01918608T AT01918608T ATE395601T1 AT E395601 T1 ATE395601 T1 AT E395601T1 AT 01918608 T AT01918608 T AT 01918608T AT 01918608 T AT01918608 T AT 01918608T AT E395601 T1 ATE395601 T1 AT E395601T1
Authority
AT
Austria
Prior art keywords
albumin
free
concentration
plasma
determining
Prior art date
Application number
AT01918608T
Other languages
English (en)
Inventor
Bradley Arbogast
Original Assignee
Arbogast Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbogast Pharmaceuticals Inc filed Critical Arbogast Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE395601T1 publication Critical patent/ATE395601T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT01918608T 2000-03-31 2001-03-13 Verfahren zum vorhersagen von preeclampsia und anderen krankheiten ATE395601T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/540,809 US6642055B1 (en) 2000-03-31 2000-03-31 Method for the prediction of preeclampsia and other diseases

Publications (1)

Publication Number Publication Date
ATE395601T1 true ATE395601T1 (de) 2008-05-15

Family

ID=24157023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918608T ATE395601T1 (de) 2000-03-31 2001-03-13 Verfahren zum vorhersagen von preeclampsia und anderen krankheiten

Country Status (11)

Country Link
US (1) US6642055B1 (de)
EP (1) EP1269200B1 (de)
JP (1) JP4813736B2 (de)
CN (1) CN1188705C (de)
AT (1) ATE395601T1 (de)
AU (1) AU2002301109B2 (de)
CA (1) CA2404218C (de)
DE (1) DE60133997D1 (de)
EA (1) EA005275B1 (de)
MX (1) MXPA02009539A (de)
WO (1) WO2001077675A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282368B2 (en) * 2002-02-27 2007-10-16 Biomerieux, Inc. Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
ATE505731T1 (de) * 2002-12-06 2011-04-15 Denka Seiken Kk Verfahren zur quantifizierung von kleinen lipoproteinen mit geringer dichte
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
US20060212484A1 (en) * 2005-03-18 2006-09-21 Chaffin David G Jr System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders
US7586389B2 (en) * 2006-06-19 2009-09-08 Maxim Integrated Products, Inc. Impedance transformation and filter using bulk acoustic wave technology
DE102006044795A1 (de) * 2006-09-13 2008-03-27 Schweigert, Florian, Prof. Dr.med.vet. Bestimmung von Inhaltsstoffen aus biologischen Materialien
CN105021821B (zh) * 2008-10-31 2018-05-11 耶鲁大学 先兆子痫检测和治疗的方法和组合物
CN102031240B (zh) * 2009-09-24 2013-11-06 上海国睿生命科技有限公司 一种获得内皮祖细胞的方法
CN105203472B (zh) * 2015-06-30 2019-03-08 北京万泰德瑞诊断技术有限公司 一种稳定的游离脂肪酸测定试剂盒

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349625A (en) 1979-05-25 1982-09-14 Mitsubishi Chemical Industries Limited Method for assaying fatty acids
JPS5692456A (en) * 1979-12-25 1981-07-27 Toyobo Co Ltd Reference substance for measuring free fatty acid in body fluid
JPS6058095A (ja) * 1983-09-08 1985-04-04 Eiken Kagaku Kk 血清遊離脂肪酸の定量法
DE3446637A1 (de) 1984-12-20 1986-07-03 Boehringer Mannheim Gmbh, 6800 Mannheim Mittel zur verbesserung des nachweises h(pfeil abwaerts)2(pfeil abwaerts)0(pfeil abwaerts)2(pfeil abwaerts)-liefernder oxidase-reaktionen und seine verwendung
US4699878A (en) 1985-03-01 1987-10-13 East Tennessee State University Process for the determination of the toxicity preventing activity of human blood serum
US5198366A (en) 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
EP0380633A4 (en) 1988-07-11 1990-12-05 East Tennessee State University Arteriosclerosis prognostication procedure and therapeutic method
US5079171A (en) 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US5238819A (en) 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5108898A (en) 1989-01-18 1992-04-28 Peters John H Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy
JPH02222699A (ja) * 1989-02-27 1990-09-05 Konica Corp リポタンパク成分の分画方法及び分析方法
JPH0484768A (ja) * 1990-07-27 1992-03-18 Eiken Chem Co Ltd 糖付加アルブミン測定方法および測定用試薬
US5543138A (en) 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
US5534548A (en) 1994-05-03 1996-07-09 Tap Pharmaceuticals, Inc. Method of treating preeclampsia
US5811416A (en) 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
US5712103A (en) 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
US5849474A (en) 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals

Also Published As

Publication number Publication date
AU2002301109B2 (en) 2006-03-30
CN1188705C (zh) 2005-02-09
EA005275B1 (ru) 2004-12-30
CA2404218A1 (en) 2001-10-18
JP4813736B2 (ja) 2011-11-09
WO2001077675A2 (en) 2001-10-18
JP2004500581A (ja) 2004-01-08
EA200201041A1 (ru) 2003-10-30
DE60133997D1 (de) 2008-06-26
CN1420986A (zh) 2003-05-28
MXPA02009539A (es) 2003-03-10
CA2404218C (en) 2009-03-10
US6642055B1 (en) 2003-11-04
WO2001077675A3 (en) 2002-03-07
EP1269200B1 (de) 2008-05-14
EP1269200A2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
Morrow The isoprostanes: their quantification as an index of oxidant stress status in vivo
Alpert et al. α-Fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique
Schmerr et al. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy
Wu et al. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes
Kapur et al. Carbohydrate deficient transferrin: a marker for alcohol abuse.
Ichihara et al. Neurologic abnormalities in workers of a 1-bromopropane factory
ATE420204T1 (de) Verfahren zur detektion von erkrankungen
ES2112057T3 (es) Metodo de deteccion y/o cuantificacion y/o separacion de celulas apoptosicas dentro de o en una muestra.
Williams Jr et al. Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation in Type As.
Holland et al. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)
DE60133997D1 (de) Verfahren zum vorhersagen von preeclampsia und anderen krankheiten
BR9804648A (pt) Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos.
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
EP1537422A2 (de) Isoprostane als marker für psychischen stress bei menschen
Teass et al. Application of biological monitoring methods
RU2008103988A (ru) Способ диагностики рассеяного склероза
EP2016416B1 (de) In vitro verfahren zur erkennung und früherkennung und zur begleitenden kontrolle der therapie von arznei- und suchtmittelinduzierten leberschäden
Zhang et al. Plasma phospholipids are associated with mild cognitive impairment in type 2 diabetic patients
ATE472102T1 (de) Verfahren zur vorhersage von anomalien des lipidmetabolismus
Kumar et al. Standardization and validation of Vero cell assay for potency estimation of diphtheria antitoxin serum
Counsell et al. Serum bile acids: reference values in healthy dogs and comparison of two kit methods
Rajpoot et al. Toxic potential indicator
Brock et al. The Relationship Between Environmental Exposure to Phthalates and Computer-Aided Sperm Analysis Motion Parameters
Butler et al. Serum levels of fibrin (ogen) degradation fragment E antigen in the diagnosis of deep vein thrombosis after abdominal and inguinal surgery
Pauletto et al. The surface measurement of aortic atherosclerosis: critical survey and comparison with histologic findings

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties